; and (2) subject to the availability of appropriations, make grants to, or enter into contracts with, public or nonprofit private entities to conduct such research. (b) Reports The Director of the Institute shall ensure that each triennial report under section 403 includes information on actions undertaken by the National Institutes of Health to carry out subsection (a) with respect to such fungal diseases, including coccidioidomycosis. (c) Authorization of appropriations In addition to other amounts available for the purposes of carrying out this section, there is authorized to be appropriated to carry out this section $20,000,000 for each of fiscal years 2024 through 2028 for such purpose. . 3. Endemic fungal disease working group (a) Establishment The Secretary of Health and Human Services (referred to in this section as the Secretary ) shall establish a working group, to be known as the Endemic Fungal Disease Working Group (referred to in this section as the Working Group ), comprised of representatives of appropriate Federal agencies and other non-Federal entities— (1) to provide expertise and to review all efforts within the Department of Health and Human Services related to fungal disease in the United States; (2) to help ensure interagency coordination and minimize overlap with respect to such disease; and (3) to examine research priorities with respect to such disease. (b) Duties The Working Group shall— (1) make recommendations to the Secretary, including an updated strategy related to development of therapeutics and vaccines for endemic fungal diseases, that shall— (A) take into account ongoing fungal disease research, including for animals, that may be adapted for human use; (B) identify gaps in endemic fungal disease research, including basic, clinical, and translational research related to the pathogenesis, prevention, diagnosis, and treatment of such diseases; and (C) include recommendations for congressional action to spur additional research and product development for fungal diseases